Hanyang Med Rev.  2018 Jun;38(2):93-98. 10.7599/hmr.2018.38.2.93.

Microbiological Characteristics of Corynebacterium striatum, an Emerging Pathogen

• Song SA
• Shin JH

• KMID: 2431305
• DOI: http://doi.org/10.7599/hmr.2018.38.2.93

Abstract

C. striatum is part of the normal skin and mucous membrane flora in humans and is widely disseminated in the environment. Traditionally, these strains have been considered contaminants. However, C. striatum has been linked to respiratory infection, bacteremia, and endocarditis; and it is strongly related to nosocomial outbreaks. At present, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF) is the most accurate routine identification method. Many C. striatum strains are multi-drug resistant, being susceptible only to vancomycin and linezolid. We should survey the antimicrobial susceptibility results regularly to monitor its resistance and consider it a possible pathogen.

Keyword

Corynebacterium striatum; Emerging pathogen; Resistance

MeSH Terms

Bacteremia
Corynebacterium*
Disease Outbreaks
Endocarditis
Humans
Linezolid
Mass Spectrometry
Methods
Mucous Membrane
Skin
Vancomycin
Linezolid
Vancomycin

Reference

1. Qin L, Sakai Y, Bao R, Xie H, Masunaga K, Miura M, et al. Characteristics of Multidrug-Resistant Corynebacterium spp. Isolated from Blood Cultures of Hospitalized Patients in Japan. Jpn J Infect Dis. 2017; 70:152–157.

2. Severo CB, Guazzelli LS, Barra MB, Hochhegger B, Severo LC. Multiple pulmonary nodules caused by Corynebacterium striatum in an immunocompetent patient. Rev Inst Med Trop Sao Paulo. 2014; 56:89–91.

3. Bowstead TT, Santiago SM. Pleuropulmonary infection due to Corynebacterium striatum. Br J Dis Chest. 1980; 74:198–200.

4. Renom F, Gomila M, Garau M, Gallegos MD, Guerrero D, Lalucat J, et al. Respiratory infection by Corynebacterium striatum: epidemiological and clinical determinants. New Microbes New Infect. 2014; 2:106–114.

5. Hong HL, Koh HI, Lee AJ. Native Valve Endocarditis due to Corynebacterium striatum confirmed by 16S Ribosomal RNA Sequencing: A Case Report and Literature Review. Infect Chemother. 2016; 48:239–245.

6. Xu J, Yang Q, Li J, Zheng X. The left atrial bacterial vegetative mass due to Corynebacterium striatum as a presentation of myxoma: a case report. BMC Infect Dis. 2017; 17:368.

7. Molina Collada J, Rico Nieto A, Diaz de Bustamante Ussia M, Balsa Criado A. Septic arthritis in a native knee due to Corynebacterium striatum. Reumatol Clin. 2017.

8. Martin MC, Melon O, Celada MM, Alvarez J, Mendez FJ, Vazquez F. Septicaemia due to Corynebacterium striatum: molecular confirmation of entry via the skin. J Med Microbiol. 2003; 52:599–602.

9. Saito S, Kawamura I, Tsukahara M, Uemura K, Ohkusu K, Kurai H. Cellulitis and Bacteremia due to Corynebacterium striatum Identified by Matrix-assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry. Intern Med. 2016; 55:1203–1205.

10. Daisuke U, Oishi T, Yamane K, Terada K. Corynebacterium striatum Bacteremia Associated with a Catheter-Related Blood Stream Infection. Case Rep Infect Dis. 2017; 2017:2682149.

11. Park S, Chung HS, Seo EK, Mun YC, Lee M. Two cases of medical device-related corynebacterium striatum infection: a meningitis and a sepsis. Ann Clin Microbiol. 2016; 19:28–31.

12. Weiss K, Labbe AC, Laverdiere M. Corynebacterium striatum meningitis: case report and review of an increasingly important Corynebacterium species. Clin Infect Dis. 1996; 23:1246–1248.

13. Kolios AGA, Cozzio A, Zinkernagel AS, French LE, Kundig TM. Cutaneous Corynebacterium Infection Presenting with Disseminated Skin Nodules and Ulceration. Case Rep Dermatol. 2017; 9:8–12.

14. Fernandez-Ayala M, Nan DN, Farinas MC. Vertebral osteomyelitis due to Corynebacterium striatum. Am J Med. 2001; 111:167.

15. Yamamoto T, Kenzaka T, Mizuki S, Nakashima Y, Kou H, Maruo M, et al. An extremely rare case of tubo-ovarian abscesses involving corynebacterium striatum as causative agent. BMC Infect Dis. 2016; 16:527.

16. Biswal I, Mohapatra S, Deb M, Dawar R, Gaind R. Corynebacterium striatum: an emerging nosocomial pathogen in a case of laryngeal carcinoma. Indian J Med Microbiol. 2014; 32:323–324.

17. Belmares J, Detterline S, Pak JB, Parada JP. Corynebacterium endocarditis species-specific risk factors and outcomes. BMC Infect Dis. 2007; 7:4.

18. Wong KY, Chan YC, Wong CY. Corynebacterium striatum as an emerging pathogen. J Hosp Infect. 2010; 76:371–372.

19. Leal SM Jr, Jones M, Gilligan PH. Clinical Significance of Commensal Gram-Positive Rods Routinely Isolated from Patient Samples. J Clin Microbiol. 2016; 54:2928–2936.

20. Renom F, Garau M, Rubi M, Ramis F, Galmes A, Soriano JB. Nosocomial outbreak of Corynebacterium striatum infection in patients with chronic obstructive pulmonary disease. J Clin Microbiol. 2007; 45:2064–2067.

21. Verroken A, Bauraing C, Deplano A, Bogaerts P, Huang D, Wauters G, et al. Epidemiological investigation of a nosocomial outbreak of multidrug-resistant Corynebacterium striatum at one Belgian university hospital. Clin Microbiol Infect. 2014; 20:44–50.

22. Brandenburg AH, van Belkum A, van Pelt C, Bruining HA, Mouton JW, Verbrugh HA. Patient-to-patient spread of a single strain of Corynebacterium striatum causing infections in a surgical intensive care unit. J Clin Microbiol. 1996; 34:2089–2094.

23. Hahn WO, Werth BJ, Butler-Wu SM, Rakita RM. Multidrug-Resistant Corynebacterium striatum Associated with Increased Use of Parenteral Antimicrobial Drugs. Emerg Infect Dis. 2016; 22.

24. Watkins DA, Chahine A, Creger RJ, Jacobs MR, Lazarus HM. Corynebacterium striatum: a diphtheroid with pathogenic potential. Clin Infect Dis. 1993; 17:21–25.

25. Cone LA, Curry N, Wuestoff MA, O'Connell SJ, Feller JF. Septic synovitis and arthritis due to Corynebacterium striatum following an accidental scalpel injury. Clin Infect Dis. 1998; 27:1532–1533.

26. Oliva A, Belvisi V, Iannetta M, Andreoni C, Mascellino MT, Lichtner M, et al. Pacemaker lead endocarditis due to multidrug-resistant Corynebacterium striatum detected with sonication of the device. J Clin Microbiol. 2010; 48:4669–4671.

27. Boltin D, Katzir M, Bugoslavsky V, Yalashvili I, Brosh-Nissimov T, Fried M, et al. Corynebacterium striatum--a classic pathogen eluding diagnosis. Eur J Intern Med. 2009; 20:e49–e52.

28. Martinez-Martinez L, Suarez AI, Rodriguez-Bano J, Bernard K, Muniain MA. Clinical significance of Corynebacterium striatum isolated from human samples. Clin Microbiol Infect. 1997; 3:634–639.

29. Rennie RP, Brosnikoff C, Turnbull L, Reller LB, Mirrett S, Janda W, et al. Multicenter evaluation of the Vitek 2 anaerobe and Corynebacterium identification card. J Clin Microbiol. 2008; 46:2646–2651.

30. Vila J, Juiz P, Salas C, Almela M, de la Fuente CG, Zboromyrska Y, et al. Identification of clinically relevant Corynebacterium spp., Arcanobacterium haemolyticum, and Rhodococcus equi by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol. 2012; 50:1745–1747.

31. Bao R, Gao X, Hu B, Zhou Z. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry: a powerful tool for identification of Corynebacterium species. J Thorac Dis. 2017; 9:3239–3245.

32. Sana Alibi AF, Manel Marzouk, Jalel Boukadida. Identification of Clinical Corynebacterium striatum Strains by PCR-Restriction Analysis Using the RNA Polymerase β-subunit gene(rpob). J Bacteriol Parasitol. 2015; 6.

33. Theel ES, Schmitt BH, Hall L, Cunningham SA, Walchak RC, Patel R, et al. Formic acid-based direct, on-plate testing of yeast and Corynebacterium species by Bruker Biotyper matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol. 2012; 50:3093–3095.

34. Suwantarat N, Weik C, Romagnoli M, Ellis BC, Kwiatkowski N, Carroll KC. Practical Utility and Accuracy of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Identification of Corynebacterium Species and Other Medically Relevant Coryneform-Like Bacteria. Am J Clin Pathol. 2016; 145:22–28.

35. McMullen AR, Anderson N, Wallace MA, Shupe A, Burnham CA. When Good Bugs Go Bad: Epidemiology and Antimicrobial Resistance Profiles of Corynebacterium striatum, an Emerging Multidrug-Resistant, Opportunistic Pathogen. Antimicrob Agents Chemother. 2017; 61:pii: e01111-17.

36. Khamis A, Raoult D, La Scola B. Comparison between rpoB and 16S rRNA gene sequencing for molecular identification of 168 clinical isolates of Corynebacterium. J Clin Microbiol. 2005; 43:1934–1936.

37. Martinez-Martinez L, Pascual A, Bernard K, Suarez AI. Antimicrobial susceptibility pattern of Corynebacterium striatum. Antimicrob Agents Chemother. 1996; 40:2671–2672.

38. Werth BJ, Hahn WO, Butler-Wu SM, Rakita RM. Emergence of High-Level Daptomycin Resistance in Corynebacterium striatum in Two Patients with Left Ventricular Assist Device Infections. Microb Drug Resist. 2016; 22:233–237.

39. Yoo G, Kim J, Uh Y, Lee HG, Hwang GY, Yoon KJ. Multidrug-Resistant Corynebacterium striatum Bacteremia: First Case in Korea. Ann Lab Med. 2015; 35:472–473.

40. Otsuka Y, Ohkusu K, Kawamura Y, Baba S, Ezaki T, Kimura S. Emergence of multidrug-resistant Corynebacterium striatum as a nosocomial pathogen in long-term hospitalized patients with underlying diseases. Diagn Microbiol Infect Dis. 2006; 54:109–114.

41. Baio PV, Mota HF, Freitas AD, Gomes DL, Ramos JN, Sant'Anna LO, et al. Clonal multidrug-resistant Corynebacterium striatum within a nosocomial environment, Rio de Janeiro, Brazil. Mem Inst Oswaldo Cruz. 2013; 108:23–29.

42. Fernandez Guerrero ML, Molins A, Rey M, Romero J, Gadea I. Multidrug-resistant Corynebacterium striatum endocarditis successfully treated with daptomycin. Int J Antimicrob Agents. 2012; 40:373–374.

43. McElvania TeKippe E, Thomas BS, Ewald GA, Lawrence SJ, Burnham CA. Rapid emergence of daptomycin resistance in clinical isolates of Corynebacterium striatum... a cautionary tale. Eur J Clin Microbiol Infect Dis. 2014; 33:2199–2205.

44. Tran TT, Jaijakul S, Lewis CT, Diaz L, Panesso D, Kaplan HB, et al. Native valve endocarditis caused by Corynebacterium striatum with heterogeneous high-level daptomycin resistance: collateral damage from daptomycin therapy. Antimicrob Agents Chemother. 2012; 56:3461–3464.

45. van Hal SJ, Paterson DL, Gosbell IB. Emergence of daptomycin resistance following vancomycin-unresponsive Staphylococcus aureus bacteraemia in a daptomycin-naive patient--a review of the literature. Eur J Clin Microbiol Infect Dis. 2011; 30:603–610.

46. Montero CI, Stock F, Murray PR. Mechanisms of resistance to daptomycin in Enterococcus faecium. Antimicrob Agents Chemother. 2008; 52:1167–1170.

47. Tang S, Yao L, Hao X, Zhang X, Liu G, Liu X, et al. Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in China. Eur Respir J. 2015; 45:161–170.

48. Sader HS, Jones RN, Stilwell MG, Flamm RK. Ceftaroline activity tested against uncommonly isolated Gram-positive pathogens: report from the SENTRY Antimicrobial Surveillance Program (2008-2011). Int J Antimicrob Agents. 2014; 43:284–286.

49. Goldstein EJ, Citron DM, Merriam CV, Tyrrell KL. Comparative in vitro activity of ceftaroline, ceftaroline-avibactam, and other antimicrobial agents against aerobic and anaerobic bacteria cultured from infected diabetic foot wounds. Diagn Microbiol Infect Dis. 2013; 76:347–351.